I’m with you again Denial!
the fact the outcome measures maintain the DMOAD monitoring measurements AND don’t include bloodwork up for biomarker analysis points at the quality of the 008 datasets and our genuine chance at DMOAD label.
Im glass half full with the 2x2 mg dose here but I’m not going to get too excited until announced to market.
Great work Donna and other KOL.
Let’s see what SW and Matt can do regarding fund if 2x2 and DMOAD are live chances.
Where we at?, page-279
-
- There are more pages in this discussion • 428 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 23.0¢ | $85.35K | 365.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 280011 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 44703 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |